Analysed BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) News Sources
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
Yahoo Finance
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), BridgeBio Pharma (BBIO) and Establishment Labs Holdings (ESTA)
The Globe and Mail
Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc.
MarketWatch
What is the current price of BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ)?
The current price of BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) is $10.42.
BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) absolute price change since previous trading day?
The absolute price change of BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) since the previous trading day is $0.53.
BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) percentage price change since previous trading day?
The percentage price change of BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) since the previous trading day is 5.36%.
What is This Week's average sentiment score for BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ)?
This Week's average sentiment score for BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) is 75 out of 100.
What is This Week's average sentiment for BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ)?
This Week's sentiment for BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.